Valmark Advisers, Inc. Abbott Laboratories Transaction History

Valmark Advisers, Inc.

$6.34 Billion
Q3 2024

A detailed history of Valmark Advisers, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Valmark Advisers, Inc. holds 15,753 shares of ABT stock, worth $1.83 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

15,753

Previous 15,873 0.76%

Holding current value

$1.83 Million

Previous $1.65 Million 8.85%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	SELL	$100.07 - $118.13 $12,008 - $14,175	-120 Reduced 0.76%	15,753 $1.8 Million
Q2 2024 Jul 31, 2024	BUY	$100.73 - $112.44 $39,083 - $43,626	388 Added 2.51%	15,873 $1.65 Million
Q1 2024 May 03, 2024	SELL	$109.52 - $120.96 $1,423 - $1,572	-13 Reduced 0.08%	15,485 $1.76 Million
Q4 2023 Feb 02, 2024	SELL	$90.19 - $110.4 $2,074 - $2,539	-23 Reduced 0.15%	15,498 $1.71 Million
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $22,545 - $27,050	236 Added 1.54%	15,521 $1.5 Million
Q2 2023 Aug 02, 2023	SELL	$100.78 - $112.29 $9,977 - $11,116	-99 Reduced 0.64%	15,285 $1.67 Million
Q1 2023 May 01, 2023	BUY	$96.86 - $114.01 $40,874 - $48,112	422 Added 2.82%	15,384 $1.56 Million
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $28,708 - $33,679	302 Added 2.06%	14,962 $1.64 Million
Q3 2022 Nov 02, 2022	SELL	$96.76 - $112.03 $15,578 - $18,036	-161 Reduced 1.09%	14,660 $1.42 Million
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $11,431 - $13,817	-112 Reduced 0.75%	14,821 $1.61 Million
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $115,274 - $140,569	1,011 Added 7.26%	14,933 $1.77 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $1,964 - $2,404	17 Added 0.12%	13,922 $1.96 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $9,799 - $10,841	-84 Reduced 0.6%	13,905 $1.64 Million
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $57,126 - $67,246	540 Added 4.02%	13,989 $1.62 Million
Q1 2021 May 04, 2021	BUY	$108.84 - $128.23 $28,624 - $33,724	263 Added 1.99%	13,449 $1.61 Million
Q4 2020 Feb 03, 2021	BUY	$105.0 - $114.42 $1.07 Million - $1.16 Million	10,151 Added 334.46%	13,186 $1.44 Million
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $6,414 - $7,790	-70 Reduced 2.25%	3,035 $330,000
Q2 2020 Jul 31, 2020	BUY	$76.57 - $98.0 $612 - $784	8 Added 0.26%	3,105 $284,000
Q1 2020 May 01, 2020	BUY	$62.82 - $91.86 $9,862 - $14,422	157 Added 5.34%	3,097 $244,000
Q4 2019 Jan 31, 2020	SELL	$78.51 - $87.4 $82,356 - $91,682	-1,049 Reduced 26.3%	2,940 $255,000
Q3 2019 Nov 06, 2019	BUY	$81.84 - $88.74 $42,065 - $45,612	514 Added 14.79%	3,989 $334,000
Q2 2019 Aug 07, 2019	SELL	$72.88 - $85.0 $5,684 - $6,630	-78 Reduced 2.2%	3,475 $292,000
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $2,317 - $2,802	-35 Reduced 0.98%	3,553 $284,000
Q4 2018 Feb 07, 2019	BUY	$65.56 - $74.27 $24,519 - $27,776	374 Added 11.64%	3,588 $260,000
Q3 2018 Nov 02, 2018	BUY	$60.81 - $73.36 $195,443 - $235,779	3,214 New	3,214 $236,000

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valmark Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Valmark Advisers, Inc. with notifications on news.

Account

Valmark Advisers, Inc. Abbott Laboratories Transaction History